2020 Q4 Form 10-Q Financial Statement

#000140658721000010 Filed on January 27, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $307.1M $247.2M
YoY Change 24.23% 542.08%
Cost Of Revenue $262.9M $216.6M
YoY Change 21.38% 605.54%
Gross Profit $44.20M $30.60M
YoY Change 44.44% 292.31%
Gross Profit Margin 14.39% 12.38%
Selling, General & Admin $15.50M $10.50M
YoY Change 47.62% 84.21%
% of Gross Profit 35.07% 34.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $800.0K $1.900M
YoY Change -57.89% 35.71%
% of Gross Profit 1.81% 6.21%
Operating Expenses $15.50M $10.50M
YoY Change 47.62% 84.21%
Operating Profit $28.70M $20.10M
YoY Change 42.79% 857.14%
Interest Expense $500.0K $2.200M
YoY Change -77.27%
% of Operating Profit 1.74% 10.95%
Other Income/Expense, Net
YoY Change
Pretax Income $29.20M $22.20M
YoY Change 31.53% 353.06%
Income Tax $7.100M $5.400M
% Of Pretax Income 24.32% 24.32%
Net Earnings $22.00M $16.90M
YoY Change 30.18% 412.12%
Net Earnings / Revenue 7.16% 6.84%
Basic Earnings Per Share $0.46 $0.35
Diluted Earnings Per Share $0.46 $0.35
COMMON SHARES
Basic Shares Outstanding 48.13M shares 48.01M shares
Diluted Shares Outstanding 48.19M shares 48.07M shares

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $237.4M $373.3M
YoY Change -36.41% 142.09%
Cash & Equivalents $237.4M $373.3M
Short-Term Investments
Other Short-Term Assets $3.000M $2.400M
YoY Change 25.0% -31.43%
Inventory
Prepaid Expenses
Receivables $300.0K $1.100M
Other Receivables $0.00 $0.00
Total Short-Term Assets $240.7M $376.8M
YoY Change -36.12% 135.35%
LONG-TERM ASSETS
Property, Plant & Equipment $1.900M $900.0K
YoY Change 111.11% -50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.000M $5.900M
YoY Change -83.05% -20.27%
Other Assets $11.80M
YoY Change -71.63%
Total Long-Term Assets $1.569B $1.103B
YoY Change 42.19% 45.41%
TOTAL ASSETS
Total Short-Term Assets $240.7M $376.8M
Total Long-Term Assets $1.569B $1.103B
Total Assets $1.809B $1.480B
YoY Change 22.25% 61.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $42.20M $19.80M
YoY Change 113.13% 167.57%
Accrued Expenses $66.10M $63.60M
YoY Change 3.93% 120.07%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $228.1M $173.1M
YoY Change 31.77% 65.65%
LONG-TERM LIABILITIES
Long-Term Debt $654.1M $462.1M
YoY Change 41.55% 309.3%
Other Long-Term Liabilities $25.00M $9.800M
YoY Change 155.1% -20.97%
Total Long-Term Liabilities $679.1M $471.9M
YoY Change 43.91% 276.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $228.1M $173.1M
Total Long-Term Liabilities $679.1M $471.9M
Total Liabilities $915.1M $654.3M
YoY Change 39.86% 171.83%
SHAREHOLDERS EQUITY
Retained Earnings $240.9M $175.0M
YoY Change 37.66% 36.29%
Common Stock $652.2M $650.5M
YoY Change 0.26% 18.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $893.1M $825.5M
YoY Change
Total Liabilities & Shareholders Equity $1.809B $1.480B
YoY Change 22.25% 61.09%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $22.00M $16.90M
YoY Change 30.18% 412.12%
Depreciation, Depletion And Amortization $800.0K $1.900M
YoY Change -57.89% 35.71%
Cash From Operating Activities -$158.7M -$11.60M
YoY Change 1268.1% -92.93%
INVESTING ACTIVITIES
Capital Expenditures $100.0K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $2.100M $3.100M
YoY Change -32.26% 3000.0%
Cash From Investing Activities $2.000M $3.100M
YoY Change -35.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$200.0K -$1.000M
YoY Change -80.0% 66.67%
NET CHANGE
Cash From Operating Activities -$158.7M -$11.60M
Cash From Investing Activities $2.000M $3.100M
Cash From Financing Activities -$200.0K -$1.000M
Net Change In Cash -$156.9M -$9.500M
YoY Change 1551.58% -94.23%
FREE CASH FLOW
Cash From Operating Activities -$158.7M -$11.60M
Capital Expenditures $100.0K $0.00
Free Cash Flow -$158.8M -$11.60M
YoY Change 1268.97% -92.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001406587
CY2020Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2020Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q4 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 dei Document Type
DocumentType
10-Q
CY2020Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q4 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q4 dei Entity File Number
EntityFileNumber
001-33662
CY2020Q4 dei Entity Registrant Name
EntityRegistrantName
FORESTAR GROUP INC.
CY2020Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1336998
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7900000 USD
CY2020Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
2221 E. Lamar Blvd., Suite 790
CY2020Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Arlington
CY2020Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2020Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76006
CY2020Q4 dei City Area Code
CityAreaCode
817
CY2020Q4 dei Local Phone Number
LocalPhoneNumber
769-1860
CY2020Q4 dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
CY2020Q4 dei Trading Symbol
TradingSymbol
FOR
CY2020Q4 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48076643 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
237400000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
394300000 USD
CY2020Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1540500000 USD
CY2020Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1309700000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1000000.0 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
3600000 USD
CY2020Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
2100000 USD
CY2020Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
6300000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1900000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1100000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
26300000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
24900000 USD
CY2020Q4 us-gaap Assets
Assets
1809200000 USD
CY2020Q3 us-gaap Assets
Assets
1739900000 USD
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
42200000 USD
CY2020Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
29200000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
118500000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
98300000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
48100000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
604100000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
603900000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
240900000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
218900000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
893100000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
870900000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1000000.0 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
900000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
894100000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
871800000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1809200000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1739900000 USD
CY2020Q4 us-gaap Revenues
Revenues
307100000 USD
CY2019Q4 us-gaap Revenues
Revenues
247200000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
262900000 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
216600000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15500000 USD
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10500000 USD
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
200000 USD
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
500000 USD
CY2020Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2019Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-100000 USD
CY2020Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
300000 USD
CY2019Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1700000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29200000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22200000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7100000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5400000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
22100000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
16800000 USD
CY2020Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
100000 USD
CY2019Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
22000000.0 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
16900000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48100000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48000000.0 shares
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48200000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48100000 shares
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
871800000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
22100000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
300000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
894100000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
808900000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
16800000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2019Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
200000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
500000 USD
CY2019Q4 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
400000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
825600000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
22100000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
16800000 USD
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
800000 USD
CY2019Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1900000 USD
CY2020Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2200000 USD
CY2019Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
5600000 USD
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
200000 USD
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
500000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5700000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
300000 USD
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
500000 USD
CY2020Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
400000 USD
CY2019Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
300000 USD
CY2020Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2019Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-100000 USD
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
218600000 USD
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
92400000 USD
CY2020Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
93800000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
654100000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
641100000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
915100000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
868100000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48076643 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48061921 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
48100000 USD
CY2019Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38200000 USD
CY2020Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4200000 USD
CY2019Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
600000 USD
CY2020Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2600000 USD
CY2019Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
700000 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11600000 USD
CY2019Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3400000 USD
CY2020Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
21100000 USD
CY2019Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-200000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-158700000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11600000 USD
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100000 USD
CY2019Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2020Q4 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2100000 USD
CY2019Q4 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1800000 USD
CY2020Q4 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 USD
CY2019Q4 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
1300000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2000000.0 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3100000 USD
CY2020Q4 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2019Q4 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
400000 USD
CY2020Q4 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
100000 USD
CY2019Q4 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
400000 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
100000 USD
CY2019Q4 us-gaap Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
200000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-200000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1000000.0 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-156900000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9500000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
394300000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
382800000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
237400000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
373300000 USD
CY2020Q4 us-gaap Notes Issued1
NotesIssued1
12500000 USD
CY2019Q4 us-gaap Notes Issued1
NotesIssued1
0 USD
CY2020Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2020Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1540500000 USD
CY2020Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1309700000 USD
CY2020Q4 us-gaap Payments To Acquire Residential Real Estate
PaymentsToAcquireResidentialRealEstate
295100000 USD
CY2020Q4 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
181900000 USD
CY2020Q4 for Due Diligence Write Offs
DueDiligenceWriteOffs
400000 USD
CY2019Q4 for Due Diligence Write Offs
DueDiligenceWriteOffs
300000 USD
CY2020Q4 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
100000 USD
CY2019Q4 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
100000 USD
CY2020Q4 us-gaap Revenues
Revenues
307100000 USD
CY2019Q4 us-gaap Revenues
Revenues
247200000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
48700000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
23700000 USD
CY2020Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
11500000 USD
CY2019Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
9900000 USD
CY2020Q4 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
9200000 USD
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
3800000 USD
CY2020Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
51000000.0 USD
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
29800000 USD
CY2020Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
300000 USD
CY2020Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
400000 USD
CY2020Q4 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
3800000 USD
CY2020Q3 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
4800000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5000000.0 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3600000 USD
CY2020Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3000000.0 USD
CY2020Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
4900000 USD
CY2020Q4 us-gaap Deposits Assets
DepositsAssets
10000000.0 USD
CY2020Q3 us-gaap Deposits Assets
DepositsAssets
5500000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
4200000 USD
CY2020Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
5700000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
26300000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
24900000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
2800000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
6200000 USD
CY2020Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
800000 USD
CY2020Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
3800000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5300000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3800000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10900000 USD
CY2020Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14000000.0 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200000 USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
9300000 USD
CY2020Q3 us-gaap Deferred Revenue
DeferredRevenue
9300000 USD
CY2020Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1300000 USD
CY2020Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
500000 USD
CY2020Q4 for Accrued Development Costs
AccruedDevelopmentCosts
42500000 USD
CY2020Q3 for Accrued Development Costs
AccruedDevelopmentCosts
35300000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
3800000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
10200000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
15700000 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
10500000 USD
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
92400000 USD
CY2020Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
93800000 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
641100000 USD
CY2020Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
380000000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
654100000 USD
CY2020Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
570000000 USD
CY2020Q4 for Letterof Credit Maximum Borrowing Capacity
LetterofCreditMaximumBorrowingCapacity
100000000 USD
CY2020Q4 for Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment
LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment
0.50
CY2020Q4 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2020Q4 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
40500000 USD
CY2020Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
339500000 USD
CY2020Q2 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 USD
CY2020Q4 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
22000000.0 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
16900000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48129222 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48011132 shares
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
63673 shares
CY2019Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
55286 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48192895 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48066418 shares
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7100000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5400000 USD
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2020Q4 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
-6400000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1500000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7900000 USD
CY2020Q3 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
-4200000 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1500000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5700000 USD
CY2018Q3 for Equity Securities Registered Value
EquitySecuritiesRegisteredValue
500000000 USD
CY2020Q4 for Common Stock Availablefor Issuance Value Remaining
CommonStockAvailableforIssuanceValueRemaining
394300000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
24000 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
237400000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
394300000 USD
CY2020Q4 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
100000000 USD
CY2020Q4 for At The Market Equity Offering Program Common Stock Issued
AtTheMarketEquityOfferingProgramCommonStockIssued
0 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.08
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
300000 USD
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
500000 USD
CY2020Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
40500000 USD
CY2020Q4 us-gaap Special Assessment Bond
SpecialAssessmentBond
293800000 USD
CY2020Q4 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
77500 Lot
CY2020Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
60500 Lot
CY2020Q4 for Numberof Lots Sold
NumberofLotsSold
3567 Lot
CY2019Q4 for Numberof Lots Sold
NumberofLotsSold
2422 Lot

Files In Submission

Name View Source Status
0001406587-21-000010-index-headers.html Edgar Link pending
0001406587-21-000010-index.html Edgar Link pending
0001406587-21-000010.txt Edgar Link pending
0001406587-21-000010-xbrl.zip Edgar Link pending
a12312020exhibit311.htm Edgar Link pending
a12312020exhibit312.htm Edgar Link pending
a12312020exhibit321.htm Edgar Link pending
a12312020exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
for-20201231.htm Edgar Link pending
for-20201231.xsd Edgar Link pending
for-20201231_cal.xml Edgar Link unprocessable
for-20201231_def.xml Edgar Link unprocessable
for-20201231_htm.xml Edgar Link completed
for-20201231_lab.xml Edgar Link unprocessable
for-20201231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending